Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Monness, Crespi, Hardt Downgrades Elastic to Neutral

Monness, Crespi, Hardt Downgrades Elastic to Neutral

Monness, Crespi, Hardt analyst Brian White downgrades Elastic (NYSE:ESTC) from Buy to Neutral.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Monness, Crespi, Hardt analyst Brian White downgrades Elastic (NYSE:ESTC) from Buy to Neutral.

Analyst Ratings

Analyst Expectations for LyondellBasell Industries’s Future

By Benzinga Insights

February 24, 1:00 PM

Within the last quarter, LyondellBasell Industries (NYSE:LYB) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

LYB

Verona Pharma To Announce Top-line Data From Phase 3 ENHANCE-1 Trial Of Nebulized Ensifentrine For COPD On Tuesday, December 20, 2022

By Benzinga Newsdesk

December 19, 5:02 PM

Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces it will report top-line Phase 3 data from its

VRNA